SlidesetVaccine and drugs pipeline and trials; passive immunization (convalescent serum) and regulatory issues - Peter Kilmarx, MD, FACP, FIDSAView Slideset
SlidesetResponding to an epidemic: perspective from Sierra Leone and Guinea - Peter Kilmarx, MD, FACP, FIDSAView Slideset
SlidesetProgress in HIV prevention and treatment scale-up in sub-Saharan Africa - Sheila TlouView Slideset
SlidesetPreventing HIV infection in young women – does money matter? - Sinéad Delany-Moretlwe, MBBCh, PhDView Slideset
SlidesetFemale-initiated HIV Prevention Methods: Past, Present and Future - Nyaradzo Mgodi, MBChB, MMedView Slideset
SlidesetPrEP, learning from post-trial and demonstration projects - Kenneth Ngure, BSc, MPH, EMOD, MSc, PhDView Slideset
SlidesetThe price of selling sex: HIV among female sex workers—Context and the public health response - Euphemia Sibanda, PhDView Slideset
SlidesetLatest findings from Zimbabwe’s ongoing STI etiology study - Kees Rietmeijer, PhD, MD, MSPHView Slideset
SlidesetUpdate on STI diagnostics, e.g., use of Gene-Xpert for GC/CT testing - Francis NdowaView Slideset
SlidesetImplementing the new WHO post-exposure prophylaxis guidelines - François Venter, MD, FCP, PhDView Slideset
SlidesetBeyond IRIS TB, how common is tuberculosis among patients on ART? - Patrick KatayamoyoView Slideset
SlidesetAssessing linkage between HIV-testing and care/treatment, by mode of HIV-testing in public hospitals in South-rift Kenya - Jamlick Mutugi M’MuriithiView Slideset
SlidesetSex differences in uptake of HIV services in Nigeria: Implications for future programming - Maiya SalehView Slideset
SlidesetUse of Satellite Clinics to Improve the Health Outcomes of HIV Clients at Chilonga MIssin Hospital, Zambia - Ernest MwilaView Slideset
SlidesetCervical cancer screening programmes: A case of an antiretroviral access programme in a resource limited setting - Margie PascoeView Slideset
SlidesetImproving PMTCT services through a participatory Continuous Quality Improvement (CQI) approach in Nyanza region of Western Kenya - Margaret MburuView Slideset
SlidesetDebate: PrEP is ready for prime time in Africa- Team opposing the motion - Gaby GomezView Slideset
SlidesetDebate: PrEP is ready for prime time in Africa - Team opposing the motion - François Venter, MD, FCP, PhDView Slideset
SlidesetViral load monitoring: Challenges and innovation in laboratory diagnostic implementation - Madisa MineView Slideset
SlidesetReservoirs and HIV Cure in Adults and Children: Insights and Challenges - Caroline TiemessenView Slideset
SlidesetAntiretroviral therapy update: impact of the 2014 WHO guidelines and improving the cascade in resource-limited settings - Nathan Ford, MPH, PhD, FRCPEView Slideset
SlidesetProgrammatic progress and challenges: rollout and devices - Karin Hatzold, MD, MPHView Slideset
SlidesetDelays in confirming suspected treatment failure and in switching to second line antiretroviral therapy in Kenya - John Paul OtienoView Slideset
SlidesetAdherence assessment techniques in adolescents receiving protease inhibitor based antiretroviral therapy in a resource limited setting - Tinashe MudzvitiView Slideset
SlidesetPretreatment HIV drug resistance increases regimen switch in sub-Saharan Africa - Bernice HoenderboomView Slideset
SlidesetHIV Infection Among Patients With Sexually Transmitted Infections in Zimbabwe - Morblessing MungatiView Slideset
SlidesetRetention and long-term virologic outcomes in children and adolescents receiving HIV/ART care at a public sector tertiary level hospital in Zimbabwe - Janneke van DijkView Slideset
SlidesetEarly Infant Diagnosis Data Transmission System Using Mobile Phones in Zimbabwe - Kenzy ChidawanyikaView Slideset
SlidesetDelays in initiation of antiretroviral therapy among HIV-infected children in rural Zambia - Francis HamangabaView Slideset
SlidesetOptimising uptake of PrePex circumcision among adult males through a mobile caravan in Chitungwiza town, Zimbabwe - Pesanai ChatikoboView Slideset
SlidesetANRS TasP, Africa Centre for Health and Population Studies Hlabisa, KZN - Joseph LarmarangeView Slideset
SlidesetPrinciples and reality of HIV drug resistance in sub-Saharan Africa - Bruce RichmanView Slideset
SlidesetBuilding laboratory networks and systems to prevent, detect and respond to antimicrobial resistance in Africa - Talkmore MarutaView Slideset
SlidesetAntimalarial Drug Resistance in South Africa: Past, Present and Future! - Jaishree RamanView Slideset
SlidesetApproach to management of HIV – understanding the unmet medical needs with our current use of antiretroviral drugs - François Venter, MD, FCP, PhDView Slideset
SlidesetHas the current management of HIV reached a plateau or can we go further? - Harold KesslerView Slideset
